South Korea Responds to Trump's Claim: Paracetamol and Autism
South Korea's drug regulator plans to gather information from pharmaceutical companies following U.S. President Donald Trump's unsupported claim linking Tylenol use during pregnancy to autism. Despite affirmations from international health agencies that paracetamol is safe during pregnancy, the South Korean ministry will review relevant documents and data.
South Korea's food and drug safety ministry announced plans to gather information from pharmaceutical companies after President Donald Trump made unsupported claims about Tylenol and autism.
International health agencies, including the World Health Organization, have reiterated that there is no conclusive scientific link between paracetamol use during pregnancy and autism.
The European Medicines Agency has advised using the minimum effective dose, ensuring its continued approval for use during pregnancy.
(With inputs from agencies.)
Advertisement
ALSO READ
WHO Debunks Autism and Paracetamol Link
WHO: No Evidence Linking Paracetamol During Pregnancy to Autism
Paracetamol in Pregnancy: Unveiling the Risks and Reality
Experts Debunk Trump's Paracetamol-Autism Claim in Press Conference Standoff
EU and UK Reaffirm Paracetamol's Safety in Pregnancy Amid U.S. Controversy
Google News